Vilya Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 46

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $71M

  • Investors
  • 9

Vilya General Information

Description

Developer of a biotechnology platform designed to create medicines that precisely target disease biology. The company's platform builds molecular structures that range in size and antibodies, with critical drug-like properties, including the ability to move through biological membranes and to disrupt protein interactions, enabling doctors to effectively treat patients.

Contact Information

Website
www.vilya.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 188 East Blaine Street
  • Suite 124
  • Seattle, WA 98102
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 188 East Blaine Street
  • Suite 124
  • Seattle, WA 98102
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vilya Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 04-Jun-2024 $71M Completed Generating Revenue
2. Seed Round Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Vilya’s complete valuation and funding history, request access »

Vilya Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Seed 927,161 $0.000100 $3 $3 1x $3 2.9%
To view Vilya’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vilya Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to create medicines that precisely target disease biology. The company's
Drug Discovery
Seattle, WA
46 As of 2026

Emeryville, CA
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vilya Competitors (41)

One of Vilya’s 41 competitors is Octant, a Venture Capital-Backed company based in Emeryville, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Octant Venture Capital-Backed Emeryville, CA
Genevant Corporate Backed or Acquired Vancouver, Canada
etherna Formerly VC-backed Niel, Belgium
Atalanta Therapeutics Venture Capital-Backed Boston, MA
Accent Therapeutics Venture Capital-Backed Lexington, MA
You’re viewing 5 of 41 competitors. Get the full list »

Vilya Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vilya Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Altitude Life Science Ventures Venture Capital Minority
ARCH Venture Partners Venture Capital Minority
Lifeforce Capital Venture Capital Minority
Madrona Venture Group Venture Capital Minority
Menlo Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Vilya FAQs

  • When was Vilya founded?

    Vilya was founded in 2022.

  • Where is Vilya headquartered?

    Vilya is headquartered in Seattle, WA.

  • What is the size of Vilya?

    Vilya has 46 total employees.

  • What industry is Vilya in?

    Vilya’s primary industry is Drug Discovery.

  • Is Vilya a private or public company?

    Vilya is a Private company.

  • What is the current valuation of Vilya?

    The current valuation of Vilya is .

  • What is Vilya’s current revenue?

    The current revenue for Vilya is .

  • How much funding has Vilya raised over time?

    Vilya has raised $73.8M.

  • Who are Vilya’s investors?

    Altitude Life Science Ventures, ARCH Venture Partners, Lifeforce Capital, Madrona Venture Group, and Menlo Ventures are 5 of 9 investors who have invested in Vilya.

  • Who are Vilya’s competitors?

    Octant, Genevant, etherna, Atalanta Therapeutics, and Accent Therapeutics are some of the 41 competitors of Vilya.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process